Market Research Briefing · Healthcare
Hemodialysis Market Global Outlook 2020–2030: Renal Care at the Intersection of Demographic Shift, Technological Innovation, and Emerging-Market Expansion
Executive Summary The global Hemodialysis Market is a USD 78.30 billion category in 2019, forecast to reach USD 116.66 billion by 2030 at a 3.60% CAGR. Growth is driven by escalating ESRD prevalence, diabetes and hypertension co-morbidities, donor-organ shortages, and a structural shift toward home and nocturnal dialysis. North America leads in adoption; Asia-Pacific delivers the highest incremental upside.
Market Size (2019)
Forecast (2030)
CAGR · 2 0 2 0 –20 30
$78.30Bn
$116.66Bn
3.60%
Global market valuation, 2019 base
Projected global valuation by 2030
Compound annual growth rate, 11-
year
year horizon
Industry Ecosystem at a Glance HD Machines
Water Treatment Systems
Aftermarket Services
Hospitals & Centers
Dialyzers & Bloodlines
HD Consumables & Fluids
Homecare HD
© Next Move Strategy Consulting · www.nextmsc.com · Confidential — For Internal & Investor Use
Slide 02 · Market Landscape
Sizing the Opportunity A US$38 Bn Incremental Revenue Pool Over 11 Years The global hemodialysis market advances from US$78.30 Bn (2019) to US$116.66 Bn (2030), a +US$38.36 Bn absolute uplift at a 3.60% CAGR — anchored by structural ESRD demand and steadily expanding treatment capacity worldwide.
Global Market Size (US$ Billion)
Market Share by Geography
2019 base year vs. 2030 forecast
Estimated share of global 2023 revenue
130
$116.66 100
75
$78.30
50
0
North America ~41%
Europe ~27%
Asia-Pacific ~17%
Rest of World ~15%
Indicative split based on dialysis prevalence and treatment
2019 Base Year
2030 Forecast
infrastructure maturity.
Δ +US$38.36 Bn · CAGR 3.60%
Why This Market is Compelling for Investors Recurring, non-discretionary demand — dialysis is life-sustaining treatment for ESRD patients; volumes decouple from economic cycles. WHO projects global dialysis need will double by 2030 — from 2.62 M patients in 2010, mathematically widening the addressable funnel. Mix shift toward consumables and services — multi-procedure per-week cadence (3–6 sessions) drives annuity-like revenue for consumables, fluids, and aftermarket services. North America leads installed base & reimbursement sophistication — accounting for the largest share and the highest per-patient revenue intensity. Asia-Pacific delivers the highest growth rate — emerging-economy R&D investment, early-diagnosis awareness, and untapped patient pools anchor upside.
© Next Move Strategy Consulting · www.nextmsc.com · Source: NextMSC Hemodialysis Market Report
Slide 03 · Growth Drivers & Opportunities
Where the Next $38 Bn Comes From Four Demand Pillars, Three High-velocity Segments, Two Anchor Geographies ▍Demand Drivers
ESRD Prevalence
Co-morbidities
Donor Shortage
WHO Projection
Rising end-stage renal disease caseload expands the addressable patient base worldwide.
Surging diabetes & hypertension cases create a long tail of future dialysis candidates.
Persistent shortage of transplant kidneys keeps chronic dialysis as the default modality.
WHO: global dialysis need is projected to double by 2030 vs. 2010 baseline (2.62M).
▍High-Growth Segments 01 · Modality
02 · Offering
03 · Service
Home & Nocturnal HD
HD Consumables & Dialyzers
Aftermarket & Training
Out-of-center modalities deliver higher per-patient revenue, payer savings, and patient preference tailwinds. Fastest-growing modality →
High-frequency, recurring use per treatment — annuity-like revenue across the installed base lifetime.
Install, maintain, train — high-margin services attach to every machine sale across the operator's lifespan. Margin-rich tail →
Largest revenue segment →
▍Regional Opportunities Growth Opportunity Heatmap
Strategic Region Ranking Asia-Pacific — highest CAGR Rising R&D investment, early-diagnosis adoption, and emergingeconomy patient pools.
North America — largest share Mature reimbursement, established providers, and premium-tier adoption.
Europe — stable mid-core Color intensity = growth velocity · Asia-Pacific is the standout velocity market.
Universal coverage markets with technology refresh opportunities and home-HD momentum.
Rest of World — emerging frontier Brazil, Saudi Arabia, South Africa — first-mover advantage for capable operators.
© Next Move Strategy Consulting · www.nextmsc.com · Source: NextMSC Hemodialysis Market Report
Slide 04 · Competitive Scenario
The 10-Player Field & How to Win A Consolidated Oligopoly Where Scale, Vertical Integration, and Geography Decide the Race ▍Key Strategic Moves Competitive Positioning Matrix Bubble size ≈ estimated market footprint · axes: portfolio breadth × geographic reach High portfolio breadth ↑ Q1 · GLOBAL LEADERS
Fresenius
Q2 · REGIONAL CHALLENGERS
Medical Care
Diaverum · Oct 2019 Acquired INEDI (Brazil), adding 8 renal care centers and 3,000+ patients. Reinforces the EM expansion playbook.
★ Global Leader
DaVita Integrated U.S. network
Diaverum
Baxter
EMEAfocused
Filters + CRRT
B. Braun
EU Pure-play
NxStage
FDA EUA for Oxiris filter set — CRRT in COVID-19 ICU patients. Diversifies revenue into adjacent bloodpurification indication.
Fresenius & DaVita
Portable HD
Cantel
Infection control
Baxter · Apr 2020
Nipro
Nikkiso
Dialyzers
Japan machines
Asahi Kasei
Vertical integration: clinic ownership, in-house dialyzer production, dialysis-drug R&D. Defensive moat against new entrants.
Membranes
Q3 · DOMESTIC FOCUSED
Q4 · NICHE INNOVATORS High geographic reach →
Q1 = scale + global reach · Q4 = specialized technology or regional focus
Niche Players Technology-led bets: NxStage in portable HD, Nikkiso / Nipro in machines & dialyzers, Asahi Kasei in specialty membranes.
▍Strategic Implications for Investors & B2B Decision -Makers P L AY 0 1
P L AY 0 2
P L AY 0 3
Back the Incumbents
Watch the EM Roll-up
Niche Innovation
Scale players (Fresenius, DaVita, Baxter) hold the strongest moat through integration and installed base.
Diaverum-style acquisition plays (Latin America, MEA, SEA) unlock the highest marginal-growth upside.
Portable / nocturnal / home HD (NxStage, B. Braun) command premium per-patient revenue and brand pull.
Profiled Market Players (per NextMSC report) Asahi Kasei Corporation · Cantel Medical Corp. · DaVita, Inc. · Diaverum · Fresenius Medical Care AG & Co. KGaA · Nikkiso Co., Ltd. · B. Braun Melsungen AG · Baxter International, Inc. · Nipro Corporation · NxStage Medical, Inc.
© Next Move Strategy Consulting · www.nextmsc.com · Source: NextMSC Hemodialysis Market Report
Next Move Strategy Consulting
Thank You For in-depth insights, custom research, and strategic guidance on the Hemodialysis Market — connect with our team.
Click Here
Get the Full Report
Click Here
357-page market research · 202 figures · 202 tables · Forecast to 2030
▍Direct Contact Website
Call Us
www.nextmsc.com
+1 (857) 758-5017
info@nextmsc.com
F o l l ow Us gen-dedup-309303a4f89577f2ee4efef4e172ba39.png
gen-dedup-309303a4f89577f2ee4efef4e172ba39.png
gen-dedup-fe4754a19a59c299e30ef6570a71f646.png
gen-dedup-309303a4f89577f2ee4efef4e172ba39.png
YouTube
gen-dedup-fe4754a19a59c299e30ef6570a71f646.png
Twitter / X
Every market number in this briefing is sourced from the Next Move Strategy Consulting Hemodialysis Market report — verifiable, defensible, and ready for investor due diligence.
"Decision-grade market intelligence — for investors, internal strategy teams, and B2B decision-makers." © Next Move Strategy Consulting · www.nextmsc.com · Confidential — For Internal & Investor Use